Molecular and Pharmacological Mapping of Perioperative Anesthetic Agents in Indonesia: A Critical Evaluation of Halal Compliance, Excipient Lineages, and Islamic Bioethics
Bimo Kusumo Bhirowo, Amalia Tri Utami*, Aasiyah Muzaahim, Al Haarits Harrats and Maryam Aali 'Imroon
ABSTRACT
The institutionalization of halal pharmaceutical frameworks has transformed from a theological preference into an essential benchmark of patient autonomy and contemporary clinical ethics, particularly within Muslim-majority nations like Indonesia. Within the complex landscape of anesthesiology, selecting perioperative agents presents significant ethical and pharmacological challenges due to the intricate molecular lineage of active pharmaceutical ingredients (APIs) and auxiliary excipients. This study provides a comprehensive molecular and legal mapping of the most widely utilized anesthetic agents in Indonesian healthcare facilities. Using a narrative review framework integrating international biochemical standards with traditional Islamic jurisprudence (Maqashid al-Shariah), we evaluate the critical control points of active compounds, solvents, stabilizers, and plasma expanders. The results demonstrate that while a substantial majority of modern synthetic volatile gases and local anesthetics are inherently permissible, profound halal vulnerabilities persist in lipid emulsions requiring animal-derived lecithins or polyols, and macromolecular plasma expanders. Crucially, porcine-derived materials remain prevalent in standard perioperative anticoagulants like systemic heparin, requiring the legal invocation of the principle of medical necessity (Al-Darurat Tubih al Mahzurat). This review establishes an authoritative clinical and ethical guide for healthcare providers to optimize informed consent, support patient spiritual integrity, and stimulate green-synthesis pharmacological innovations.
